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ABSTRACT 
Objective To determine the prevalence and types of complementary and alternative 
medications (CAMs) used by menopausal women living in South-East Queensland, 
Australia; and profile the women who are using CAMs through sociodemographic 
characteristics, self-rated health status, lifestyle and preventative health strategies. 
Method This study was a secondary data analysis of data collected by postal 
questionnaire from 886 women aged 48–67 years participating in the Queensland 
Midlife Women’s Health Study. The outcome measure was CAM use, distinguished by three 
categories: herbal therapies, phytoestrogens and nutritional intake (supplements and healthy 
eating). 
 
Results The overall prevalence of CAM use among mid-life Australian women was 
82% which included therapeutic techniques (83%), nutritional supplements (66.8%), 
phytoestrogens (55.8%), herbal therapies (41.3%), Evening Primrose oil (34%) and 
vitamin E (28.8%). CAM users, when compared to non-users, were more likely to be 
previous (p50.05) but not current users (p50.05) of hormone therapy (HT), higher 
educated (p50.05), low to middle income earners (p50.001) and have participated in 
self-breast examination (p50.01). They were also more likely to report good general 
health (p50.05) and improved physical functioning without limitations due to health 
(p50.05). CAM users were less likely to be aged over 55 years (p50.05) and smoke 
more than 20 cigarettes per day (p50.001). 
Conclusions/implications for health research As prevalence of current CAM use in this 
population group is considerably higher than HT use, health education programs to assist mid-
life women to understand the scientific evidence (or lack of it) for their 
efficacy is recommended. 
 
INTRODUCTION 
Improving current and future health status and well-being is an important consideration 
during menopause1. Symptoms of menopause, particularly 
vasomotor symptoms such as hot flushes and night sweats, can adversely affect the quality of 
a woman’s life2,3. The symptoms associated with use of complementary and alternative 
medications (CAMs) during menopause have been previously 
explored in a study of 886 Australian menopausal women; anxiety and vasomotor symptoms 
were a predictor of CAM use during the menopause4. Factors such as changes in social, 
emotional and physical health, which often coincide with the 
menopause transition, can also affect women’s health and are just as relevant and important to 
measure as vasomotor symptoms. A qualitative exploration of the experiences of 16 
menopausal women found that menopause itself was not 
considered an important event; however, health, family and marriage problems occurring 
during the menopause transition were perceived as crucial and detrimental to health5. 
 
CAMs have been broadly defined by the World Health Organization to include a wide range 
of medications, beliefs, techniques and exercises6 and, from the perspective of menopause, 
they have the potential to address menopause symptoms as well as improve general health 
status. This definition highlights the importance of CAMs as a multitreatment approach to 
prevent illness and maintain well-being, rather than to treat or cure illness. While clinical 
trials have been undertaken to test the clinical effectiveness of specific CAMs including 
phytoestrogens8–11 and herbal therapies 
such as Chinese herbs12 and dong quai13, the literature indicates that the treatment effect is 
often equal or exhibits no change to the placebo. For example, for phytoestrogens, a decrease 
in the frequency of flushes or symptoms was evident, 
although, in most cases, participants in the placebo group also experienced a similar decrease 
8–11,14–18. Despite a lack of scientific evidence proving the efficacy of CAMs, the use of 
CAMs is evident in both the general and menopause literature. In Australia, a study of adults 
found that just over one-half were using at least one non-physician-prescribed CAM, with a 
further 27% using two or more19. The study also 
indicated an increase in women’s use of CAMs from 55% in 1993 to 60% in 2000 (p50.01). 
In the American population, a 7-year follow-up study found a 36% increase in visits to 
alternative practitioners and a 65% increase in the total 
 
CAMs used between 1990 and 199720. Specifically, the literature signified that women, 
particularly Caucasian and of menopausal age, were more likely to use CAMs19–23. Studies 
with Western menopausal women have indicated that CAM use ranged from 22 to 61%24–26. 
In American women aged 45–65 years, 22% used CAMs to treat menopausal symptoms; 
herbal and naturopathic remedies (13%) were the most common, followed by relaxation (9%) 
and dietary soy supplements (7%)26. In 1604 American menopausal women, 48.5%, used at 
least one CAM, with nutritional remedies (31.8%) the most commonly cited27. In the 
Australian context, 14% of women used CAMs specifically to treat menopausal symptoms24 
and, in a further study of women aged 45–54 years, 61% consumed healthy foods and 61% 
participated in regular physical activity25. 
  
The reviewed literature has reflected that, despite a lack of scientific evidence about the 
efficacy of CAMs in reducing symptoms, women are using CAMs during menopause. This 
present study has two aims: first, to quantify the prevalence and types of CAMs used by 
women living in South-East Queensland during the 
menopause and, second, to profile the women who are using CAMs during this transition 
through sociodemographic characteristics, selfrated health status, lifestyle and preventative 
health strategies. 
 
METHODS 
Subjects 
Participants were a cross-sectional sample of women aged between 45 and 60 years living in 
South-East Queensland, Australia. Women living within one of six postcodes selected to 
present urban and rural areas were randomly selected from the electoral roll. From this 
sample, 1500 women were randomly selected to participate in 
the study. Of the 1500 questionnaires distributed, 886 were completed and returned for 
analysis, giving an overall response rate of 59%. Ethical approval was granted by Queensland 
University of Technology Human Ethics Committee. 
 
Data collection 
A 73-item postal questionnaire was sent to participants to collect information on 
sociodemographic characteristics, menopausal status, selfrated health status, menopausal 
symptoms and the Complementary medicine in mid-life Australian women Gollschewski et 
al. 272 Climacteric types of medications and therapies used during the menopause. Data on 
menopausal symptoms were also collected and the results are published elsewhere 4. 
Sociodemographic data included age, education 
level, income, employment status and ethnicity. Menopausal status was determined by 
questions relating to menstrual history, used with permission from McKinlay at the New 
England Research Institute, Boston. Women were grouped into four categories: 
premenopausal, with no irregularity in the past year and had menstruated in the previous 3 
months; perimenopausal, with irregular menstruation over the previous year but had 
menstruated in past 3 months or irregular menstruation over the previous year but no 
menstruation in past 3 months; postmenopausal, did not menstruate in the previous year; and 
surgical menopause, hysterectomy and/or a bilateral 
oophorectomy. Self-rated health status over the previous month was measured using the 
Short-Form 36 (SF-36), a generic tool which measures eight dimensions of 
physical and mental health status: general health, physical functioning, social functioning 
(impact of health on social activities), role limitations: emotional 
(restrictions due to emotional health), role limitations: physical (restrictions due to physical 
health), vitality, mental health, and bodily pain28. It has been administered internationally in 
over 260 clinical trials28 and, in the context of menopause, the SF-36 has been used to 
compare the quality of life of users and non-users of 
hormone therapy (HT)29,30 and women attending primary care clinics31. 
 
CAM use in the sample was measured in three categories: herbal therapies, phytoestrogens 
and nutritional intake. A list of eight herbal therapies was provided including wild yam cream, 
topical progesterone cream, dong quai, black cohosh, 
vitamin E, Evening Primrose oil, ginseng and red clover, and women were asked to indicate if 
they had ever used these supplements for menopausal symptoms. Phytoestrogen intake was 
measured by the current use of supplements, including Promensil and Phytolife, and whether 
women had consumed any of the 11 dietary phytoestrogens listed, including soy and linseed 
products over the previous month. Nutritional intake was measured through healthy eating, 
defined as eating healthy 
foods to improve health, and dietary supplements, including vitamins or minerals consumed 
over the previous month. Lifestyle factors were measured by smoking 
status and current or previous use of HT. Preventative health strategies were measured by 
women’s use of professional breast screening, Papanicolaou smears and breast self-
examinations performed within the past 2 years.  
 
Statistical analysis 
Characteristics of the sample were described using frequencies. Unadjusted odds ratios were 
used to identify associations; these relationships were investigated at the multivariate level 
using binary logistic regression after adjustment for demographics 
factors, self-rated health status, lifestyle and preventative health strategies. Data are 
presented as the odds ratio (OR) with 95% confidence interval (CI). Analysis of the SF-36 
was undertaken according to the SF-36 Health Survey Manual and Interpretation Guide28. 
Outof-range values were recoded as missing and items 
were reverse-scored as specified and, where necessary, missing values were substituted with 
mean total scores. Raw scores were calculated for each of the eight dimensions and then re-
coded to create transformed scale scores. Scoring checks 
were performed to ensure accuracy of the scores produced28. The scores are situated on a 
scale of 1–100, with a higher score indicating a better rate of self-perceived health status. 
Scores are presented as the mean (standard deviation). The 
Statistical Package for Social Science (SPSS version 10) was used for the quantitative data 
analysis and statistical significance for this study was set at p50.05. 
 
RESULTS 
 
Table 1 Prevalence of use of complementary and alternative medications in the sample 
Variables  
 
Percentage  n 
Herbal therapies*  
 
41.3  886 
Evening Primrose oil  
 
34.0  698 
Vitamin E  
 
28.8  663 
Ginseng  
 
13.3  633 
Red clover  
 
10.5  627 
   
Nutrition  
 
66.8  886 
Healthy eating  
 
64.9  613 
Nutritional supplements  
 
47.0  872 
   
Phytoestrogens  
 
55.8  886 
Phytoestrogen supplements  
 
33.0  224 
Phytoestrogens consumed in 
diet 
 
60.6  
 
725 
 
*Wild yam cream, dong quai, black cohosh and tropical progesterone cream were less than 10% respectively 
 
CAM use and demographic, self-rated health status, lifestyle factors and 
preventative health strategies Women who used herbal therapies were more 
likely to experience good general health, (OR = 1.01, CI = 1.00–1.02; p = 0.03), be aged 
under 55 years (OR = 0.72, CI = 0.53–0.99; p = 0.05), have previously used HT (OR = 1.76, 
CI = 1.16–2.68; p = 0.008) and participated in self breast examinations over the previous 2 
years (OR = 1.69, CI = 1.34–2.52; p = 0.01), but were 
less likely to be current users of HT (OR = 0.63, CI = 0.41–0.97; p = 0.04). 
Women who used phytoestrogens were more likely to experience good physical functioning 
without limitations due to health (OR= 1.01, CI = 1.00–1.02; p = 0.02), be aged under 55 
years (OR = 0.73, CI = 0.53–0.99; p = 0.05) and have obtained trade/technical qualifications 
(OR = 2.33, CI = 1.44–3.77; p = 0.001) or university 
degree (OR = 1.81, CI = 1.15–2.84; p = 0.010). Women who used nutrition were more likely 
to experience good physical functioning without limitations due to health (OR = 1.01, CI = 
1.00– 1.02; p = 0.04), be educated for more than 10 years, with a linear trend towards CAM 
use with increasing education levels: 11–12 years (OR = 1.76, CI = 1.09–2.82; p50.05), 
trade/technical (OR = 2.02, CI = 1.21–3.39; p 40.05), 
university (OR = 2.47, CI = 1.48–4.12; p 40.001). Women who used nutrition were also more 
likely to be low to middle income earners (OR = 2.29, CI = 1.41–3.71; p = 0.001), have 
participated in self-breast examinations over the previous 2 years (OR = 1.68, CI = 1.13–2.50; 
p = 0.01) but less likely to smoke more than 20 cigarettes per day (OR = 0.18, CI = 0.07–
0.47; p = 0.000). No statistically significant associations 
were present between herbal therapies, phytoestrogens and nutritional intake for employment 
status, menopause status, social functioning, mental health, role-emotional, role-physical, 
vitality, body pain, professional breast checks and Papanicolaou smears. These results are 
summarized in Figure 1 to present the profile of a CAM user during menopause. 
 
 
 
 
 
DISCUSSION 
CAMs have been broadly defined by the World Health Organization to include a wide range 
of medications, beliefs, techniques and exercises6. In the current study, CAMs were defined 
to include both ingestible medications and therapies, and were grouped within three 
categories. The findings indicate that, in this population-based sample of 
menopausal women aged 45–67 years in South-East Queensland, Australia, the use of CAMs 
is high, with 82% of women reported using at least one type of CAM. The most commonly 
cited CAM was nutritional intake (67%), followed by phytoestrogens (56%) and herbal 
therapies (41%). 
 
In the general American and Australian populations, the prevalence of CAM use ranged from 
42 to 60%20,23, with 11–16% citing use of herbal therapies and 6–41% using vitamins. In 
studies of American menopausal women, 22% had used CAMs specifically to treat 
menopausal symptoms, with herbal and naturopathic remedies (13%), relaxation (9%) and 
dietary soy supplements (7%) the three most 
commonly used26. The prevalence was higher in Japanese women aged 40–59 years, where 
76% cited use of at least one CAM, with healthy eating habits (44%) the most commonly 
used CAM32. However, comparisons with the previous 
literature are limited since the concept of CAMs and the modalities included in this 
group are debatable and widely varied in different studies. For example, in a study by 
Eisenberg and colleagues (1998) in 1539 adult Americans in 1991 and in a further 2055 in 
1997, CAM use was measured as one of 16 therapies including relaxation techniques, herbal 
medicine, massage, vitamins, spiritual healing, energy healing and acupuncture20. Our 
definition of CAMs included herbal therapies, phytoestrogens consumed via the diet and 
supplementation and nutritional intake measured 
through healthy eating and nutritional supplementation. Methodological differences in 
the sampling frames, tools used to measure CAMs and the time frame of CAM use could also 
have contributed to the observed variation in prevalence. 
 
This study also sought to profile the type of women using CAMs during the menopause by 
exploring the associations between the three CAM categories and demographic, self-rated 
health status, lifestyle or preventative health 
characteristics (Figure 1). Users of at least one CAM category were 1.7–2.5 times more likely 
to have higher education levels, a low to middle income, be aged under 55 years, previous 
users of HT and have participated in self-breast examination; CAM users were 40–90% less 
likely to be currently using HT or to smoke more than 20 cigarettes per day. The consistency 
of these associations varied across the different CAM categories. For example, trends towards 
a higher education level were 
observed with one category; the trend towards decreased smoking was observed across two 
CAM categories, while associations with HT or younger age were observed in one or two 
categories, respectively. The SF-36 questionnaire reported health status in eight dimensions of 
physical, social or mental health. In our group, mean SF-36 scores were comparable to the 
norms for women of the same 
age33, especially the younger cohort aged 45–54 years, which could reflect that the majority 
of our sample (61%) were under 55 years (Table 2). Results showed that CAM users were 
more likely to experience good general health and physical 
functioning without limitations due to health. While these results suggest that CAM users 
generally perceive themselves as having better health than non-users, the magnitude of the 
effect was relatively small. Further studies are therefore required to clarify the association 
between CAM use and self-reported health status. The associations identified in our study are 
similar to those identified in a previous Australian study conducted in the general population 
by MacLennan and colleagues23, who found that CAM users were more likely to be female, 
in the 
younger age group and employed with postsecondary education. Newton and colleagues26, in 
a sample of American women, also identified that users of any alternative therapy, including 
soy products, herbal and homeopathic therapies, 
were less likely to be current users of HT. Our profile of a CAM user has some features in 
common with that of HT users1. In a study of American women aged 40–65 years, HT was 
more likely to be taken by Caucasian women aged 50–54 years, who completed high school 
and reported excellent health by self-report. HT users were also more likely to have health 
insurance, were comfortable talking to their 
doctor, had undergone health screening in the previous year including a complete physical, 
breast exam and Papanicolaou smear, and also more likely to be current users of calcium 
supplements1. 
  
Menopause is a phase of life where social and emotional changes can impact on an 
individual’s perceived health status and well-being. This study explored the prevalence and 
sociodemographic profile of CAM users in a relatively large sample of menopausal women 
from the general population. A limitation of the current study was 
apparent in the measurement and types of CAMs quantified. It is clear that women are using a 
wide range of CAMs during the menopause, despite uncertainty regarding the safety and 
efficacy of these therapies. Reasons for this phenomenon can be postulated. The concept of 
CAMs as ‘natural’ may have lead to the perception of CAMs as being safe, although, for 
many individual CAMs, scientific efficacy, tolerability and long-term safety have not been 
established34,35. Alternative explanations for the increased use of CAMs include 
dissatisfaction with medical outcomes, changing beliefs about 
health, increased access to information, and dissatisfaction with the relationship between 
doctor and patient36. The concept of empowerment, the need for women to have control over 
their menopausal symptoms and long-term health, is another consideration.  
 
The higher levels of self-reported general health, including possible improved levels of 
physical functioning, together with the increased likelihood of self-breast examinations and 
decreased intake of cigarettes may indicate the adoption of a healthy lifestyle, embracing the 
concept of holistic health, health for the mind, 
body, spirit and emotions37. The results provide information for health professionals working 
in the area of women’s health on the prevalence and range of therapies utilized during the 
menopause. 
 
CONCLUSION 
Further studies are required to explorethe complex reasoning behind the use of CAMs during 
the menopause, and women’s experiences with their health practitioner, since these also have 
the potential to influence women’s choice. As pre-valence of current CAM use in this 
population group is high, health education programs to assist 
mid-life women to understand the scientific evidence (or lack of it) for their efficacy is 
recommended.  
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